{"id":"W2754752946","doi":"10.1177/1352458517728343","title":"Two-year results from a phase 2 extension study of oral amiselimod in relapsing multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Mitsubishi Tanabe Pharma Corporation","keywords":"Multiple sclerosis; Medicine; Extension (predicate logic); Computer science; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005868417,0.001235117,0.002356364,0.0003789401,0.0004289393,0.0006527521,0.0005339202,0.001235777,0.001864958],"category_scores_gemma":[0.003468842,0.000435837,0.001266617,0.0002862356,0.0005706256,0.0007005405,0.0004865167,0.001694227,0.0004977987],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004524445,"about_ca_system_score_gemma":0.0007218479,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007630058,"about_ca_topic_score_gemma":0.001032454,"domain_scores_codex":[0.9987155,0.0006613017,0.0001077414,0.0001426449,0.0001671212,0.0002056186],"domain_scores_gemma":[0.9966807,0.0006968526,0.0007170438,0.0003670961,0.0003991995,0.001139097],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8516981,0.03878611,0.02572414,0.0004757163,0.002006884,0.000497251,0.000448597,0.001071195,0.02163809,0.00008134744,0.002734356,0.05483817],"study_design_scores_gemma":[0.3192299,0.5143291,0.1584166,0.00004766283,0.001529368,0.0005211792,0.00009032197,0.0007961408,0.002527324,0.0001415983,0.002316442,0.00005451974],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967442,0.0009484834,0.0002186754,0.0001033891,0.00003842534,0.0006946105,0.0007139795,0.00003165476,0.0005067073],"genre_scores_gemma":[0.9940076,0.0005286168,0.0005387248,0.0004118424,0.000100811,0.0008252652,0.002595314,0.00001213408,0.0009796029],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005868417,"threshold_uncertainty_score":0.03103554,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2404771545872031,"score_gpt":0.3765974129036126,"score_spread":0.1361202583164094,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}